Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00375622
Status:
COMPLETED
Last Update Posted:
2006-09-13
First Post:
2006-09-12
Brief Title:
Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
Sponsor:
Rabin Medical Center
Organization:
Rabin Medical Center
Organization Data
Organization:
Rabin Medical Center
Class:
OTHER
Study ID:
3393
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rabin Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None